| Oct 29 |
Can Mounjaro, Zepbound Help Eli Lilly Top Earnings Estimates Again?
|
| Oct 29 |
Zoetis Gears Up to Report Q3 Earnings: What's in the Offing?
|
| Oct 29 |
Novo Nordisk’s Bold Share Repurchase Strategy
|
| Oct 29 |
1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever
|
| Oct 29 |
Novo Nordisk shares seen outpacing Lilly’s after summer stumble
|
| Oct 28 |
Novo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know
|
| Oct 28 |
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?
|
| Oct 28 |
Eli Lilly’s weight-loss drug Mounjaro set for Hong Kong launch - report
|
| Oct 27 |
Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage
|
| Oct 27 |
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?
|
